logo
Plus   Neg
Share
Email

Sun Pharma Launches CEQUA In US To Treat Dry Eye Disease

India- based Sun Pharmaceutical Industries Ltd. (SUNPHARMA,524715) announced Monday the commercial launch of CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. The solution is indicated to increase tear production in patients with keratoconjunctivitis sicca or dry eye, an inflammatory disease.

CEQUA offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration. It is the first and only FDA-approved cyclosporine treatment delivered with nanomicellar or NCELL technology.

The company has also introduced CEQUA SUPPORT Specialty Pharmacy program to enable easy access for patients to obtain treatment.

CEQUA is the third product in the company's ophthalmic portfolio.

The launch follows the recent publication of results from a multicenter, randomized, double-masked, vehicle-controlled Phase 3 confirmatory study in which 744 patients with dry eye were treated either with CEQUA or its vehicle.

Paul Karpecki, O.D., FAAO, director of cornea services at the Kentucky Eye Institute in Lexington, KY, said, "Keratoconjunctivitis sicca causes symptoms of burning, stinging, itching, grittiness, and dryness, underscoring the need for tolerable drug therapy with a fast onset of action. The CEQUA clinical study results strengthen the rationale for using this product as a means to penetrate the tear film and improve drug delivery of cyclosporine into the eye."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
General Motors Co. (GM) is hiring for new workforce, after cutting about some 4,000 salaried employees early this year. According to Detroit Free Press, the auto giant is hiring for a new workforce as the company invests more money to develop electric and self-driving vehicles. Earlier this year,... Australia's Federal Court has ruled in favor of more than 1,000 women in a landmark class-action lawsuit against Johnson & Johnson after they suffered severe pain and complications from the healthcare giant's pelvic mesh implants. Johnson & Johnson and its subsidiary Ethicon were accused of hiding the risks of its pelvic mesh products. SpaceX's Starship rocket prototype was damaged while undergoing pressurization testing on Wednesday evening. Video from the vicinity of SpaceX's Boca Chica test facility in Texas showed white plumes erupt from the top part of the Starship Mark 1 vehicle while it was undergoing a pressurization test. The eruption blew off the upper bulkhead high into the air.
RELATED NEWS
Follow RTT
>